CN107456225B - Partial volume effect correction method for cerebral blood flow - Google Patents
Partial volume effect correction method for cerebral blood flow Download PDFInfo
- Publication number
- CN107456225B CN107456225B CN201710639032.XA CN201710639032A CN107456225B CN 107456225 B CN107456225 B CN 107456225B CN 201710639032 A CN201710639032 A CN 201710639032A CN 107456225 B CN107456225 B CN 107456225B
- Authority
- CN
- China
- Prior art keywords
- value
- cbf
- gray
- brain
- white
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/026—Measuring blood flow
- A61B5/0263—Measuring blood flow using NMR
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Signal Processing (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention relates to a partial volume effect correction method of cerebral blood flow, which aims to correct partial volume by using a CBF value obtained in an ASL technology and provide a more accurate algorithm for clear AD diagnosis. The CBF value and the T1 value obtained from ASL are used as input, and the CBF value of whole brain white matter, brain gray matter and cerebrospinal fluid is obtained through PVE algorithm. The CBF values after PVE correction according to the method are divided into two groups of pixel values of white brain matter and grey brain matter. Compared with the CBF value of the whole brain, the calculation result is more accurate, and the clinical diagnosis and analysis are facilitated.
Description
Technical Field
The invention relates to the field of data processing, in particular to a method for correcting partial volume effect of cerebral blood flow.
Background
Cerebral Blood Flow (CBF) is the amount of Blood Flow per unit time through the vascular structures of a certain amount of brain tissue. Is defined as the amount of blood delivered per unit of time per unit mass of human tissue in ml/100 g/min. Changes in CBF are an early indicator of brain activation and are an important indicator of assessing brain health. It is the main basis for diagnosing and treating cerebrovascular diseases such as Alzheimer's disease, cerebral infarction, cerebral hemorrhage, aneurysm, congenital arterial and venous vascular malformation and the like. At present, the means for measuring cerebral blood flow mainly consists of PET, SPECT, MRI techniques, and the like. With the increasing development of magnetic resonance imaging (mri) technology, the magnetic resonance Arterial Spin Labeling (ASL) technology has been gradually used for CBF measurement as a new completely non-invasive blood perfusion technology. When the CBF value obtained by the magnetic resonance ASL technology is used for carrying out Alzheimer Disease (AD) research, compared with the cognitive normal old people, the AD patients have different degrees of brain atrophy, particularly medial temporal lobe atrophy, the different degrees of brain atrophy can influence the registration of images, and most ASL images have 3-4 mm interlamellar spacing, so that a large amount of gray matter and white matter mixed voxels exist. Errors necessarily result if gray or white matter cerebral blood flow calculation methods are used for these voxels, so that Partial volume correction (PVE) is required for these regions to obtain accurate CBF values.
Disclosure of Invention
The invention aims to carry out partial volume correction by utilizing the CBF value obtained in the ASL technology, and provides a more accurate algorithm for clear diagnosis of AD. The CBF value and the T1 value obtained from ASL are used as input, and the CBF value of whole brain white matter, brain gray matter and cerebrospinal fluid is obtained through PVE algorithm. Because the CBF value is low, at the boundary position of the white matter cerebrospinal fluid of the whole brain gray matter, one pixel value may contain a plurality of components such as the white matter, the brain gray matter and the cerebrospinal fluid, and the value of the cerebral blood flow in each component (white matter, gray matter and cerebrospinal fluid) is greatly different, so that the CBF value of the boundary area is more accurate after partial volume correction. The main formula is as follows:
CBFpve= CBF/(PGM*ΔMGM+ PWM*ΔMWM+PCSF*ΔMCSF).
in the above formula, CBF is the cerebral blood flow perfusion value before correction, PGM, PWMAnd PCSFProbability maps of gray brain matter, white brain matter and cerebrospinal fluid are shown. Δ MGM, ΔMWMand ΔMCSFThe sub-tables represent arterial spin-labeled perfusion weighted signals of gray, white and cerebrospinal fluids, where Δ MCSFThe value is 0, since the arterial discretionary marker signal of cerebrospinal fluid is almost 0. CBF in adultsgrayThe value is about WMCBF3 times the value. The above equation can therefore be simplified to:
CBFpve= CBF/ (PGM*3+ PWM).
this simplified formula is used to make PVE corrections to ASL data.
The invention is realized by the following technical scheme:
a method for correcting partial volume effect of cerebral blood flow is characterized by comprising the following steps:
step one), acquiring a cerebral blood flow value, a brain grey matter value and a brain white matter value of the whole brain according to a detection result of a nuclear magnetic artery spin labeling sequence;
step two), setting the brain gray value of an area with the brain gray value less than or equal to 0.25 as 0, and setting the area with the brain gray value not equal to 0 as GM; setting the white matter value of a region with the white matter value less than or equal to 0.25 as 0, and setting the obtained region with the white matter value not equal to 0 as WM;
step three) for each numerical point in the area GM, the correction is carried out according to the following formula
CBFgray=CBF/(GMgray+0.33*GMwhite)
Wherein CBFgrayThe correction result of the cerebral blood flow value in the gray matter of the point is CBF which is the cerebral blood flow value of the point, GMgrayThe gray brain value, GM at that pointwhiteThe white matter value of the point;
for each value point in the area WM, the correction is made as follows
CBFwhite=CBF/(WMwhite+3*WMgray)
Wherein CBFwhiteIs the correction of the cerebral blood flow value in the white matter of the spot, CBF is the cerebral blood flow value of the spot, WMwhiteTo the white matter value of the point, WMgrayThe grey brain matter value of the point;
step four) according to CBFgrayMaking a brain gray matter brain blood flow chart according to the values of the above (CBF)whiteThe cerebral leukoencephalogram is prepared by the numerical values of (A).
Compared with the prior art, the invention has the following advantages:
the CBF values after PVE correction according to the method are divided into two groups of pixel values of white brain matter and grey brain matter. Compared with the CBF value of the whole brain, the calculation result is more accurate, and the clinical diagnosis and analysis are facilitated.
Drawings
FIG. 1 is a CBF map of the whole brain;
figure 2 is a corrected gray matter CBF map.
Detailed Description
Example 1
The method can be realized by adopting matlab programming, and the matlab program is as follows:
function FG_PVE_correction_for_perfusiondata(Imgs,Grays,Whites,smooth_kernel)
defining a PVE function with four function variables (whole brain, white matter, gray matter, smooth kernel parameters)
sub = [1,2,3,4,5,6,7, …, n ] (a read image number, n is a data number of an incoming program)
for k =1: x (x represents the number of data entering the program)
n = sub (k) (n represents the number of data)
S = num2str (n); (changing from a character variable to a number variable)
Imgs = strcat ('local path \ means', S, '. img') obtaining a whole brain pixel value
Grays = stricat (' local path ' \\ ', ' c1S ', S, '. img ') acquires gray matter pixel values
Whites = strcat ('local path \', 'c2S', S, '. img') acquires a white matter pixel value
smooth _ kernel = [ 222 ], and the number of smooth cores is defined as 2
for i =1: size (Grays,1) read brain data
Vmat = spm _ vol (Imgs (i); assigning whole brain pixel values to the Vmat variable
V = spm _ read _ vols (Vmat); reading Vmat variable into V variable
GM = spm _ read _ vols (spm _ vol (Grays (i)))), gray matter data is assigned to GM
WM = spm _ read _ vols (spm _ vol (Whites (i)))), white matter data is assigned to WM
GM (find (GM < =0.25)) =0, and gray matter is 0 or less with a gray matter value of 0.25
WM (find (WM < =0.25)) =0, white matter is 0 with white matter number less than or equal to 0.25
V21= zeros (size (V); V21 variable space size is defined as equal to V (brain space size), and is assigned a value of 0
V22= zeros (size (V); V22 variable space size is defined as equal to V (brain space size), and is assigned a value of 0
V21(find(GM))=V(find(GM))./(GM(find(GM))+0.4*WM(find(GM)));
V21 (grey matter) = grey matter/(grey matter +0.33 x white matter)
V22(find (WM) = V (find (WM))/(WM (find (WM)) +2.5 GM (find (WM)); V22 (white matter) = white matter/(white matter +3 grey matter)
Vmat.fname=deblank(PVE_gray_imgs(i,:));
spm_write_vol(Vmat,V21);
Assigning the value of V21 to PVE _ gray _ imgs
Vmat.fname=deblank(PVE_white_imgs(i,:));
spm_write_vol(Vmat,V22);
The value of V22 is assigned to PVE _ white _ imgs
end
fprintf ('\n-----PVE correction is done!......\n')
GUI interface prompting that PVE calibration has been completed
end
Fig. 1 and 2 show the correction effect of the method, and the CBF values after PVE correction according to the method are divided into two groups of cerebral blood flow images of white matter and gray matter. Fig. 2 is a corrected gray matter brain blood flow chart, and compared with a whole brain CBF value, the calculation result is more accurate, and clinical diagnosis and analysis are facilitated.
Claims (1)
1. A method for correcting partial volume effect of cerebral blood flow is characterized by comprising the following steps:
step one), acquiring a cerebral blood flow value, a brain grey matter value and a brain white matter value of the whole brain according to a detection result of a nuclear magnetic artery spin labeling sequence;
step two), setting the brain gray value of a point with the brain gray value less than or equal to 0.25 as 0, and setting the obtained area with the brain gray value not being 0 as GM; setting the white matter value of a point with the white matter value less than or equal to 0.25 as 0, and taking the obtained area with the white matter value not equal to 0 as WM;
step three) for each numerical point in the area GM, the correction is carried out according to the following formula
CBFgray=CBF/(GMgray+0.33*GMwhite)
Wherein CBFgrayThe correction result of the cerebral blood flow value in the gray matter of the point is CBF which is the cerebral blood flow value of the point, GMgrayThe gray brain value, GM at that pointwhiteThe white matter value of the point;
for each value point in the area WM, the correction is made as follows
CBFwhite=CBF/(WMwhite+3*WMgray)
Wherein CBFwhiteIs the correction of the cerebral blood flow value in the white matter of the spot, CBF is the cerebral blood flow value of the spot, WMwhiteTo the white matter value of the point, WMgrayThe grey brain matter value of the point;
step four) according to CBFgrayMaking a brain gray matter brain blood flow chart according to the values of the above (CBF)whiteThe cerebral leukoencephalogram is prepared by the numerical values of (A).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710639032.XA CN107456225B (en) | 2017-07-31 | 2017-07-31 | Partial volume effect correction method for cerebral blood flow |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710639032.XA CN107456225B (en) | 2017-07-31 | 2017-07-31 | Partial volume effect correction method for cerebral blood flow |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107456225A CN107456225A (en) | 2017-12-12 |
CN107456225B true CN107456225B (en) | 2020-06-09 |
Family
ID=60547074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710639032.XA Active CN107456225B (en) | 2017-07-31 | 2017-07-31 | Partial volume effect correction method for cerebral blood flow |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107456225B (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1028482C (en) * | 1991-12-04 | 1995-05-24 | 中国人民解放军海军医学研究所 | Electroencephalogram imaging system and cerebral blood flow map imaging method |
WO2009146388A1 (en) * | 2008-05-28 | 2009-12-03 | The Trustees Of Columbia University In The City Of New York | Voxel-based methods for assessing subjects using positron emission tomography |
US8165371B2 (en) * | 2008-07-21 | 2012-04-24 | Siemens Medical Solutions Usa, Inc. | Enhanced contrast MR system accommodating vessel dynamic fluid flow |
US10078123B2 (en) * | 2014-04-18 | 2018-09-18 | The General Hospital Corporation | System and method for correcting intrinsic heterogeneity in magnetic resonance imaging |
CN105654485B (en) * | 2015-12-30 | 2017-04-26 | 中国人民解放军第四军医大学 | Magnetic resonance arterial spin labeling sequence partial volume correction method using spatio-temporal information |
CN106127792B (en) * | 2016-07-22 | 2018-10-30 | 杭州师范大学 | Magnetic resonance arterial spin labeling brain perfusion imaging data artefact figure minimizing technology |
-
2017
- 2017-07-31 CN CN201710639032.XA patent/CN107456225B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN107456225A (en) | 2017-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Krogsrud et al. | Development of white matter microstructure in relation to verbal and visuospatial working memory—a longitudinal study | |
US20240055126A1 (en) | Medical Image Segmentation Using Deep Learning Models Trained with Random Dropout and/or Standardized Inputs | |
Das et al. | Anterior and posterior MTL networks in aging and MCI | |
Benson et al. | MRI of the internal auditory canal, labyrinth, and middle ear: how we do it | |
Shi et al. | Diffusion tensor imaging–based characterization of brain neurodevelopment in primates | |
US11227390B2 (en) | Systems and methods for image processing | |
CN108333543B (en) | Magnetic resonance imaging method and apparatus | |
CN111127428A (en) | Method and system for extracting target region based on brain image data | |
JP2018075075A5 (en) | ||
Donnelly‐Kehoe et al. | Reliable local dynamics in the brain across sessions are revealed by whole‐brain modeling of resting state activity | |
JP2015208679A (en) | Magnetic resonance imaging apparatus, method, and program | |
Preti et al. | A novel approach of groupwise fMRI-guided tractography allowing to characterize the clinical evolution of Alzheimer's disease | |
Dijkstra et al. | Diminished liver microperfusion in Fontan patients: A biexponential DWI study | |
Backhaus et al. | Early parietofrontal network upregulation relates to future persistent deficits after severe stroke—a prospective cohort study | |
Chou et al. | A preliminary report of longitudinal white matter alterations in patients with end-stage renal disease: a three-year diffusion tensor imaging study | |
CN107456225B (en) | Partial volume effect correction method for cerebral blood flow | |
KR102298253B1 (en) | Method and apparatus for brain image correction using brain structure | |
CN106137198A (en) | A kind of MR imaging method and device | |
US10420485B2 (en) | Method for acquiring a vascular wall image from magnetic resonance imaging | |
JP6827120B2 (en) | Medical information display devices, methods and programs | |
CN116230245A (en) | Disease course prediction method, device, electronic equipment and storage medium | |
Bajaj et al. | Vulnerability to mood degradation during sleep deprivation is influenced by white-matter compactness of the triple-network model | |
CN110739078B (en) | Aneurysm rupture risk assessment method and system | |
Adanyeguh et al. | Brain MRI detects early-stage alterations and disease progression in Friedreich ataxia | |
Lipp et al. | Investigating the Anatomy and Microstructure of the Dentato-rubro-thalamic and Subthalamo-ponto-cerebellar Tracts in Parkinson's Disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |